ConductScience.org, home

Paper23636668

Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.

Lee JW and 8 others. Int J Hematol, 2013. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry. Papers, record 23636668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23636668

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.
PubMed
Journal
Int J Hematol
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
3.5
iCite
Revised in PubMed
2021-10-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee JWJong Wook
2Jang JHJun Ho
3Kim JSJin Seok
4Yoon SSSung-Soo
5Lee JHJe-Hwan
6Kim YKYeo-Kyeoung
7Jo DYDeog-Yeon
8Chung JJooseop
9Sohn SKSang Kyun

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hemoglobinuria, ParoxysmalMajor topic
ThrombosisMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Child
Female
Humans
Lactate Dehydrogenases
Male
Middle Aged
Prognosis
ROC Curve
Registries
Republic of Korea
Retrospective Studies
Risk Factors
Thromboembolism
Young Adult

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01224483Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) PatientsDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115985537Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria.Blood2005https://conductscience.org/library/papers/15985537PubMed
220433987Thrombosis in Paroxysmal Nocturnal Hemoglobinuria - insights into the role of complement in thrombosis.Thromb Res2010https://conductscience.org/library/papers/20433987PubMed
322639982Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function.Br J Haematol2012https://conductscience.org/library/papers/22639982PubMed
415811985The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.JAMA2005https://conductscience.org/library/papers/15811985PubMed
51578962Hemolytic anemias. Diagnosis and management.Med Clin North Am1992https://conductscience.org/library/papers/1578962PubMed
67688991Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.Blood1993https://conductscience.org/library/papers/7688991PubMed
78774569Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.Lancet1996https://conductscience.org/library/papers/8774569PubMed
818055865Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.Blood2008https://conductscience.org/library/papers/18055865PubMed
916464755Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria.Haematologica2005https://conductscience.org/library/papers/16464755PubMed
1021455865Thrombosis in patients with paroxysmal nocturnal hemoglobinuria.Semin Thromb Hemost2011https://conductscience.org/library/papers/21455865PubMed
117539996Nitric oxide in the regulation of blood flow and arterial pressure.Annu Rev Physiol1995https://conductscience.org/library/papers/7539996PubMed
1216051736Diagnosis and management of paroxysmal nocturnal hemoglobinuria.Blood2005https://conductscience.org/library/papers/16051736PubMed
1321460245Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.Blood2011https://conductscience.org/library/papers/21460245PubMed
1417702897Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.Blood2007https://conductscience.org/library/papers/17702897PubMed
1521447004Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.Eur J Haematol2011https://conductscience.org/library/papers/21447004PubMed
1620658586Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.Am J Hematol2010https://conductscience.org/library/papers/20658586PubMed
1715118546Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.Medicine (Baltimore)2004https://conductscience.org/library/papers/15118546PubMed
1816990386The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.N Engl J Med2006https://conductscience.org/library/papers/16990386PubMed
198500164Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.Cell1993https://conductscience.org/library/papers/8500164PubMed
2012893760Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH).Blood2003https://conductscience.org/library/papers/12893760PubMed

See all 31 referencesDownload CSV of references

Cited by64

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
42287326Efficacy and safety of crovalimab versus eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: Chinese subgroup analysis of the phase 3 COMMODORE 2 study.Ann Hematol2026https://conductscience.org/library/papers/42287326PubMed
41832377Thrombosis in paroxysmal nocturnal hemoglobinuria in the complement inhibitor era: mechanisms, risk stratification, and clinical management.Int J Hematol2026https://conductscience.org/library/papers/41832377PubMed
40986193Pharmacological Therapies in Paroxysmal Nocturnal Haemoglobinuria: Focus on Complement Inhibition.Drugs2025https://conductscience.org/library/papers/40986193PubMed
40886199Clinical characteristics and management of paroxysmal nocturnal hemoglobinuria in the Middle East: a narrative review.Clin Exp Med2025https://conductscience.org/library/papers/40886199PubMed
40849394Clinical Outcomes and Disease Management for Patients with Paroxysmal Nocturnal Haemoglobinuria in China: Results from a Real-World Study.Drugs Real World Outcomes2025https://conductscience.org/library/papers/40849394PubMed
40844514PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study.Ann Hematol2025https://conductscience.org/library/papers/40844514PubMed
40141144Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review.Int J Mol Sci2025https://conductscience.org/library/papers/40141144PubMed
39596227Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.Int J Mol Sci2024https://conductscience.org/library/papers/39596227PubMed
39596172Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment.Int J Mol Sci2024https://conductscience.org/library/papers/39596172PubMed
39201278Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function.Int J Mol Sci2024https://conductscience.org/library/papers/39201278PubMed
39134485[Analysis and summary of clinical characteristics of 289 patients with paroxysmal nocturnal hemoglobinuria in Zhejiang Province].Zhonghua Xue Ye Xue Za Zhi2024https://conductscience.org/library/papers/39134485PubMed
38702811Health-related quality of life and influencing factors of patients with paroxysmal nocturnal hemoglobinuria in China.Orphanet J Rare Dis2024https://conductscience.org/library/papers/38702811PubMed
38541928Fatigue Item Response among Hemoglobin-Normalized Patients with Paroxysmal Nocturnal Hemoglobinuria: PEGASUS Trial Results at 16 and 48 Weeks.J Clin Med2024https://conductscience.org/library/papers/38541928PubMed
38442722Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry.J Korean Med Sci2024https://conductscience.org/library/papers/38442722PubMed
38084255Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations.J Blood Med2023https://conductscience.org/library/papers/38084255PubMed
37668788Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.Ann Hematol2023https://conductscience.org/library/papers/37668788PubMed
37564039Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones.Front Med (Lausanne)2023https://conductscience.org/library/papers/37564039PubMed
37428869Complement and platelets: prothrombotic cell activation requires membrane attack complex-induced release of danger signals.Blood Adv2023https://conductscience.org/library/papers/37428869PubMed
37298309The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria.Int J Mol Sci2023https://conductscience.org/library/papers/37298309PubMed
37199789Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry.Ann Hematol2023https://conductscience.org/library/papers/37199789PubMed

See all 64 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23636668

GET https://conductscience.org/api/papers/v1/23636668/references?page=2